Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder Paul R. Vigano sold 750,000 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the completion of the transaction, the insider now directly owns 28,890,756 shares in the company, valued at $150,231,931.20. This trade represents a 2.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.
Aveanna Healthcare Trading Down 3.1%
Shares of AVAH stock traded down $0.16 during mid-day trading on Friday, reaching $4.93. The stock had a trading volume of 65,595 shares, compared to its average volume of 323,940. The company has a market cap of $960.84 million, a P/E ratio of -14.48 and a beta of 2.03. Aveanna Healthcare Holdings Inc. has a 12-month low of $2.32 and a 12-month high of $6.19. The business has a 50-day simple moving average of $5.09 and a 200 day simple moving average of $4.92.
Hedge Funds Weigh In On Aveanna Healthcare
Several hedge funds have recently added to or reduced their stakes in AVAH. Banque Transatlantique SA purchased a new stake in shares of Aveanna Healthcare in the first quarter valued at about $25,000. BNP Paribas Financial Markets purchased a new stake in Aveanna Healthcare in the 4th quarter valued at approximately $35,000. KLP Kapitalforvaltning AS acquired a new stake in Aveanna Healthcare during the 4th quarter valued at $35,000. Tower Research Capital LLC TRC grew its holdings in Aveanna Healthcare by 662.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock valued at $36,000 after buying an additional 6,854 shares during the last quarter. Finally, Jump Financial LLC purchased a new position in Aveanna Healthcare during the first quarter worth $59,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
AVAH has been the subject of a number of recent research reports. UBS Group increased their price target on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a research note on Friday, May 9th. Truist Financial reduced their target price on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a report on Friday, April 11th.
Get Our Latest Stock Analysis on AVAH
About Aveanna Healthcare
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Further Reading
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
